Hypoxia-driven metabolic and molecular reprogramming: From tumor microenvironment to therapeutic interventions
Pathology - Research and Practice · 2025-12 · 276 · 156271
DOI: 10.1016/j.prp.2025.156271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025-12. Verfasst von Diksha Devi und 12 weiteren Autor:innen. Beteiligte Einrichtung: L.R. Institute of Pharmacy, Jabli-kyar, Oachaghat, Solan, Himachal Pradesh, India. Electronic address: dikshasambyal91@gmail.com. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Tumor Hypoxia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 132 Literaturangaben.
Abstract (Originalsprache)
Hypoxia, characterized by reduced oxygen availability, significantly contributes to cancer development by affecting tumor growth and spread. In fast-growing tumors, the scarcity of oxygen forces cancer cells to modify their molecular structure and metabolism to survive and multiply. These alterations are predominantly governed by hypoxia-inducible factors (HIFs), with HIF-1α and HIF-2α serving crucial roles in the activation of genes related to invasion, angiogenesis, metabolic reprogramming, and metastasis. Such changes promote tumor development in low-oxygen environments and enhance resistance to conventional therapies. Hypoxia influences various aspects of cancer progression, heightening the risk of malignancy and worsening prognosis. This study investigates the fundamental mechanisms by which hypoxia influences tumor biology, including the facilitation of the epithelial-to-mesenchymal transition (EMT), the enhancement of angiogenesis through vascular endothelial growth factor (VEGF), and the metabolic shift from oxidative phosphorylation to glycolysis. In this review, we aim to elucidate the complex interaction of metabolic and molecular mechanisms within the cancer microenvironment under hypoxic conditions, which not only fosters tumor growth but also contributes to therapeutic resistance, making hypoxia a critical factor in cancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- L.R. Institute of Pharmacy, Jabli-kyar, Oachaghat, Solan, Himachal Pradesh, India. Electronic address: dikshasambyal91@gmail.com.
- ICFAI University, Baddi, Himachal Pradesh, India.
- School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
- DDM College of Pharmacy, Gondpur Banehra upper, Distt Una, Himachal Pradesh, India.
- Department of pharmacy, Chandigarh group of colleges, Jhanjeri, Mohali, Punjab, India.
- Department of Pharmacy, Vivekananda Global University, Jaipur, Rajasthan, India.
Zitieren
APA
Devi, D., Sharma, K., Khan, T., Rani, H., Rana, R., Sharma, H., Kaur, P., Prajapati, L., Rizwan, A., Allieu, M., Pal, S., Kumar, V., & Kumar, S. (2025). Hypoxia-driven metabolic and molecular reprogramming: From tumor microenvironment to therapeutic interventions. Pathology - Research and Practice, 276, 156271. https://doi.org/10.1016/j.prp.2025.156271
Vancouver
Devi D, Sharma K, Khan T, Rani H, Rana R, Sharma H, et al. Hypoxia-driven metabolic and molecular reprogramming: From tumor microenvironment to therapeutic interventions. Pathology - Research and Practice. 2025;276:156271. doi:10.1016/j.prp.2025.156271
BibTeX
@article{Devi2025,
author = {Devi, Diksha and Sharma, Kanchan and Khan, Tabish and Rani, Hema and Rana, Rekha and Sharma, Heena and Kaur, Parjinder and Prajapati, Lokesh and Rizwan, Adil and Allieu, Moses and Pal, Sampita and Kumar, Vishal and Kumar, Sunny},
title = {Hypoxia-driven metabolic and molecular reprogramming: From tumor microenvironment to therapeutic interventions},
journal = {Pathology - Research and Practice},
year = {2025},
volume = {276},
pages = {156271},
doi = {10.1016/j.prp.2025.156271}
}
EUVIMED